Foundations Investment Advisors’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,000
Closed -$797K 1213
2025
Q4
$797K Buy
+5,000
New +$687K 0.01% 575
2024
Q4
Sell
-4,617
Closed -$594K 864
2024
Q3
$594K Buy
4,617
+530
+13% +$69.2K 0.01% 481
2024
Q2
$464K Buy
4,087
+825
+25% +$88.3K 0.01% 513
2024
Q1
$433K Sell
3,262
-500
-13% -$65.3K 0.01% 498
2023
Q4
$439K Sell
3,762
-101
-3% -$7.73K 0.01% 466
2023
Q3
$294K Buy
3,863
+750
+24% +$77K 0.01% 515
2023
Q2
$369K Buy
3,113
+725
+30% +$90.3K 0.01% 428
2023
Q1
$234K Buy
2,388
+25
+1% +$3.39K 0.01% 446
2022
Q4
$334K Buy
2,363
+775
+49% +$108K 0.01% 328
2022
Q3
$223K Buy
+1,588
New +$291K 0.01% 363

Other funds holding LABU

Foundations Investment Advisors's LABU Position: Q1 2026 in Review

Foundations Investment Advisors sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2026, closing a stake of 5,000 shares — an estimated $797K sold.

Foundations Investment Advisors first reported a position in LABU in Q3 2022 and held it in 10 quarters. The position peaked at $797K in Q4 2025. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

  • Foundations Investment Advisors reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2026 after selling out during the quarter.
  • Foundations Investment Advisors sold 5,000 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2026, an estimated $797K.
  • Foundations Investment Advisors first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2022 and held it in 10 quarters.
  • Foundations Investment Advisors's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $797K in Q4 2025.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on Foundations Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.